Glomerulonephritis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
(15 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
{{Glomerulonephritis}} | {{Glomerulonephritis}} | ||
{{CMG}}; {{AE}}{{HK}} | |||
==Overview== | ==Overview== | ||
Glomerulonephritis may be proliferative or non-proliferative and may be associated with [[Nephrotic syndrome|nephrotic]] or [[Nephritic syndrome|nephritic]] features. The various types of glomerulonephritides should be differentiated from each other based on associations, presence of [[pitting edema]], hemeturia, [[hypertension]], [[hemoptysis]], [[oliguria]], peri-orbital edema, [[hyperlipidemia]], type of [[antibodies]], [[Light microscope|light]] and [[Electron microscopy|electron microscopic]] features. | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
The following table differentiates between various types of glomerulonephritides: | |||
{| class="wikitable" | {| class="wikitable" | ||
!Glomerulonephritis | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Glomerulonephritis | ||
!Sub-entity | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Sub-entity | ||
!Causes and associations | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Causes and associations | ||
!History and | ! colspan="7" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History and Symtoms | ||
! | ! colspan="9" align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory Findings | ||
|- | |- | ||
! rowspan="3" |Non-proliferative | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Hyperlipidemia and hypercholesterolemia | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Nephrotic features | |||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Nephritic features | |||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |ANCA | |||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Anti-glomerular basement membrane antibody (Anti-GBM antibody) | |||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Immune complex formation | |||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Light microscope | |||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Electron microscope | |||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Immunoflourescence pattern | |||
|- | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |History | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Pitting edema | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemeturia (pre-dominantly microscopic) | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hypertension | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemoptysis | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Oliguria | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Peri-orbital edema | |||
|- | |||
| rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Non-proliferative | |||
!Minimal change disease | !Minimal change disease | ||
| | |||
* Idiopathic | * Idiopathic | ||
* Protein tyrosine phosphatase receptor type O (glomerular epithelial protein 1- GLEPP1) | * Protein tyrosine phosphatase receptor type O (glomerular epithelial protein 1- GLEPP1) | ||
| | |||
* Young children | * Young children | ||
* Recent infection and immunization | * Recent infection and immunization | ||
Line 31: | Line 45: | ||
* Hodgkin lymphoma | * Hodgkin lymphoma | ||
* Thrombosis (due to urinary loss of antithrombin-III) | * Thrombosis (due to urinary loss of antithrombin-III) | ||
| | |||
+ | |||
| | |||
- | |||
| | |||
- | |||
| | |||
- | |||
| | |||
+/- | |||
| | |||
- | |||
| | |||
+ | |||
| | |||
+ | |||
| | |||
- | |||
| | |||
- | |||
| | |||
- | |||
| | |||
- | |||
| | |||
* Normal | * Normal | ||
| | |||
* Fusion of podocytes | |||
| | |||
- | |||
|- | |- | ||
!Focal segmental glomerulosclerosis | !Focal segmental glomerulosclerosis | ||
Line 54: | Line 87: | ||
| | | | ||
* Adults | * Adults | ||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
| + | |||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 65: | Line 103: | ||
| | | | ||
* Effacement of podocytes | * Effacement of podocytes | ||
| | |<nowiki>-</nowiki> | ||
|- | |- | ||
!Membranous glomerulonephritis | !Membranous glomerulonephritis | ||
Line 75: | Line 113: | ||
* Drugs (NSAIDS, penclliamine, gold, captopril) | * Drugs (NSAIDS, penclliamine, gold, captopril) | ||
| | | | ||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
| + | |||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 86: | Line 129: | ||
| | | | ||
* Sub-epithelial immune complex depositis with 'spike and dome' appearance | * Sub-epithelial immune complex depositis with 'spike and dome' appearance | ||
| | |<nowiki>-</nowiki> | ||
|- | |- | ||
| rowspan="7" |Proliferative | | rowspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Proliferative | ||
!IgA nephropathy | |||
| | | | ||
* Idiopathic | * Idiopathic | ||
Line 97: | Line 140: | ||
* History of mucosal infections (e.g. gastroenteritis) and upper respiratory tract infection | * History of mucosal infections (e.g. gastroenteritis) and upper respiratory tract infection | ||
* 2-3 days after infection (synpharyngitic) | * 2-3 days after infection (synpharyngitic) | ||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
| - | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 109: | Line 156: | ||
| | | | ||
* Mesangial proliferation | * Mesangial proliferation | ||
| | |<nowiki>-</nowiki> | ||
|- | |- | ||
! rowspan="5" |Rapidly progressive glomerulonephritis | |||
| | | | ||
* Goodpasture syndrome | * Goodpasture syndrome | ||
| | | | ||
* Young adults | * Young adults | ||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
| - | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | | ||
* Hypercellular and inflamed glomeruli (Crescent formation) | |||
| | | | ||
* Diffuse thickening of the glomerular basement membrane with absence of subepithelial and subendothelial deposits | |||
|<nowiki>+ (Linear)</nowiki> | |<nowiki>+ (Linear)</nowiki> | ||
|- | |- | ||
Line 133: | Line 184: | ||
* Post infectious glomerulonephritis | * Post infectious glomerulonephritis | ||
| | | | ||
* Streptococcal skin infections | * Streptococcal skin infections | ||
* Streptococcal pharyngitis | * Streptococcal pharyngitis | ||
* 2-3 weeks after infection | * 2-3 weeks after infection | ||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 150: | Line 203: | ||
| | | | ||
* Sub-epithelial immune complex deposits | * Sub-epithelial immune complex deposits | ||
| | | + (Granular) | ||
|- | |- | ||
| | | | ||
* Granulomatosis with polyangitis (Wegner's granulomatosis) | * Granulomatosis with polyangitis (Wegner's granulomatosis) | ||
| | | | ||
* Necrotizing granulomas (Nasopharynx, lungs, kidneys) | * Necrotizing granulomas (Nasopharynx, lungs, kidneys) | ||
* [[Conjunctivitis]] | * [[Conjunctivitis]] | ||
* Ulceration of the [[cornea]] | * Ulceration of the [[cornea]] | ||
* [[Episcleritis]] | * [[Episcleritis]] | ||
* Peripheral neuropathy | * Peripheral neuropathy | ||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 171: | Line 226: | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
* Crescent formation | * Hypercellular and inflamed glomeruli (Crescent formation) | ||
| | |<nowiki>- (pauci-immune)</nowiki> | ||
|<nowiki>+/-</nowiki> | |||
| | |||
|- | |- | ||
| | | | ||
* Churg Strauss syndrome | * Churg Strauss syndrome | ||
| | | | ||
* Necrotizing granulomas (Lungs and kidneys) | |||
* Necrotizing granulomas | |||
* Asthma | * Asthma | ||
* Peripheral neuropathy | * Peripheral neuropathy | ||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | | ||
+ (C-ANCA) | + (C-ANCA) | ||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
* Hypercellular and inflamed glomeruli (Crescent formation) | |||
| | |<nowiki>- (pauci-immune)</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|- | |- | ||
| | | | ||
* Microscopic polyngitis | * Microscopic polyngitis | ||
| | | | ||
* Necrotizing vasculitis (no granuloma) | * Necrotizing vasculitis (no granuloma) | ||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
| | | | ||
+ (P-ANCA) | + (P-ANCA) | ||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
* Hypercellular and inflamed glomeruli (Crescent formation) | |||
| | |<nowiki>- (pauci-immune)</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|- | |- | ||
!Membranoproliferative glomerulonephritis | |||
| | | | ||
* Idiopathic | * Idiopathic | ||
Line 226: | Line 286: | ||
* Periorbital edema | * Periorbital edema | ||
* Hypertension | * Hypertension | ||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |||
| | | | ||
* Thick glomerular basement membrane (Tram-track appearance) | |||
| | | | ||
* Mesangial proliferation and leukocyte infiltration | |||
| | |<nowiki>+ (Granular)</nowiki> | ||
|} | |} | ||
Line 243: | Line 312: | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Organ disorders]] | [[Category:Organ disorders]] | ||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
[[Category:Kidney diseases]] | [[Category:Kidney diseases]] |
Latest revision as of 21:53, 29 July 2020
Glomerulonephritis Main page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Glomerulonephritis may be proliferative or non-proliferative and may be associated with nephrotic or nephritic features. The various types of glomerulonephritides should be differentiated from each other based on associations, presence of pitting edema, hemeturia, hypertension, hemoptysis, oliguria, peri-orbital edema, hyperlipidemia, type of antibodies, light and electron microscopic features.
Differential Diagnosis
The following table differentiates between various types of glomerulonephritides:
Glomerulonephritis | Sub-entity | Causes and associations | History and Symtoms | Laboratory Findings | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hyperlipidemia and hypercholesterolemia | Nephrotic features | Nephritic features | ANCA | Anti-glomerular basement membrane antibody (Anti-GBM antibody) | Immune complex formation | Light microscope | Electron microscope | Immunoflourescence pattern | ||||||||||
History | Pitting edema | Hemeturia (pre-dominantly microscopic) | Hypertension | Hemoptysis | Oliguria | Peri-orbital edema | ||||||||||||
Non-proliferative | Minimal change disease |
|
|
+ |
- |
- |
- |
+/- |
- |
+ |
+ |
- |
- |
- |
- |
|
|
- |
Focal segmental glomerulosclerosis |
|
|
+ | - | - | - | +/- | - | + | + | - | - | - | - |
|
|
- | |
Membranous glomerulonephritis |
|
+ | - | - | - | +/- | - | + | + | - | - | - | + |
|
|
- | ||
Proliferative | IgA nephropathy |
|
|
+/- | + | + | - | + | +/- | - | - | + | - | - | + |
|
|
- |
Rapidly progressive glomerulonephritis |
|
|
+/- | + | + | + | + | + | - | - | + | - | + | + |
|
|
+ (Linear) | |
|
|
+/- | + | + | + | + | + | - | - | + | - | - | + |
|
|
+ (Granular) | ||
|
|
+/- | + | + | + | + | + | - | - | + | + (C-ANCA) | - | - |
|
- (pauci-immune) | +/- | ||
|
|
+/- | + | + | + | + | + | - | - | + |
+ (C-ANCA) |
- | - |
|
- (pauci-immune) | - | ||
|
|
+/- | + | + | + | + | + | - | - | + |
+ (P-ANCA) |
- | - |
|
- (pauci-immune) | - | ||
Membranoproliferative glomerulonephritis |
|
|
+/- | + | + | + | + | + | - | + | - | - | - | + |
|
|
+ (Granular) |